Clinical Evaluation of Siddha Medicine Inji Rasayanam for Soothaga Vaayu(PCOD)

Single Centric Non Randomized Open Clinical Trial Phase II in Soothaga Vaayu (Polycystic Ovarian Disease ) With Siddha Medicine Inji Rasayanam among patients attending OPD at Government Siddha Medical College Hospital,Chennai - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085659

Enrollment

Registered

2025-04-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Inji Rasayanam: The medicine will be given 3.15gs twice a day for three consecutive menstrual cycles Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Female aged between 15-45 years. 2.Based upon the presence of any two of the following Rotterdam criteria a. Oligo / Anovulation b. Hyperandrogenism (Clinical or Biochemical) c. Polycystic ovaries (unilateral/bilateral) 3.Seeking treatment for PCOD induced infertility

Exclusion criteria

Exclusion criteria: 1.k/c/o Thyroid dysfunction 2k/c/o Hyperprolactinemia 3.k/c/o Cushing syndrome 4.k/c/o Congenital adrenal hyperplasia 5.Any Serious systemic illness.

Design outcomes

Primary

Measure	Time frame
Regulation of Menstrual cycle and Hormonal profile .Timepoint: 3 months	—

Secondary

Measure	Time frame
Disappearance or reduction in the size or number of cysts. Timepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Menaka

Government Siddha medical college, Chennai

rangasamymenaka75@gmail.com6380932382

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026